Biological Material Analysis TRIZ Cases

Anti-CD66c antibodies target metastasis-promoting proteins to enable cancer detection while resolving diagnostic accuracy trade-offs.

Fluorescent lateral flow immunoassay replaces visual color detection with quantitative signal analysis to eliminate user misinterpretation of hormone patterns.

Capacitance spectroscopy electrode detects biomarkers via interfacial impedance changes without redox probes.

Protease-induced degradation of h2-calponin suppresses cancer growth while preserving wound healing through dynamic local control.

Electrochemical bipolar exfoliation deposits graphene nanosheets on electrodes for label-free biosensing.

Anti-telomerase antibody detects malignant cells in urine, resolving inconclusive cytology results and improving diagnostic accuracy.

A method quantifies total lipopolysaccharide concentration using mass spectrometry while measuring biological activity through a separate assay.

Anti-PD-L1 nanobody blocks PD-L1/PD-1 interaction, enhancing gamma delta T cell cytotoxicity against tumor cells.

Humanized antibodies target specific epitopes to inhibit activated protein C anticoagulant activity while preserving cytoprotective functions.

A yeast-displayed peptide-MHC library enables rapid identification of T cell receptor binding peptides through deep sequencing and computational analysis.

Labeled TNF-alpha conjugates form molecular complexes to quantify inhibitor drugs and antibodies in minimal biological samples.

Engineered synthetic antibodies target human CD10 to resolve low binding affinity in conventional diagnostic protocols.

Alkaline pretreatment disassembles parvovirus capsids without renaturation, preventing false positives from acidic methods.

Dividing steroid samples into treated liquid fractions and mixing them enables accurate LC-MS detection while reducing total analysis time.

Derives a tuberculosis biomarker signature from CD154+ T cells and central memory phenotypes to distinguish latent from active infections.

Monoclonal antibodies block TIM-3 ligand interactions, resolving insufficient targeting in cancer therapies.

A SERS-linked immunosensor assay uses engineered yeast cells to detect cellular stress proteins for rapid environmental surveillance.

Perchloric acid removes serum proteins to enable precise M1 receptor ligand binding detection.

Disrupting viral envelopes with cationic compounds removes inorganic salts that obscure diagnostic peaks, enabling sensitive MALDI-ToF detection.

Competitive elution buffers detach magnetic labels via reversible binding, preserving cell viability during separation.

Detecting stable C-terminal preproendothelin fragments overcomes rapid plasma degradation to provide reliable endothelin concentration data.

A capillary device with a separating element coated with specific agonists measures platelet plug formation time under physiological flow conditions.

Adding calcium or magnesium ions prevents EDTA-induced decomposition of the cardiac troponin complex, ensuring accurate measurement in heparinized specimens.

Mass spectral analysis of breath samples identifies specific volatile organic compound biomarkers for respiratory viral infection detection.

Engineered microbe-targeting molecules fuse carbohydrate recognition domains with Fc fragments to bind pathogens rapidly.

Antibody composite with SEQ ID NO: 08 targets influenza A intranuclear proteins, resolving cross-reactivity with type B strains.

Crystallizing the ERR-α ligand complex stabilizes reversible thioether bonds, enabling accurate dissociation rate measurement and rational drug design.

AI systems identify compounds modulating T regulatory cell activity via fuzzy logic and deep learning.

An electrochemical biosensor detects SARS-CoV-2 at ultra-low concentrations by replacing complex amplification with direct antigen binding.

Parallel transistor array converts biological binding events into electrical signals, eliminating complex mechanical steps to enable rapid viral analysis.

A portable blood analyzing device calculates parasitemia values using hemoglobin absorbance signals from a light source and detector system.

ELISPOT assay detects Mucorales-specific T cells to resolve diagnostic delay and sensitivity limits of invasive histological methods.

Multivalent polypeptides link single domain antibodies to enhance binding affinity and neutralize SARS-CoV-2 while reducing production costs.

Segmented antibody libraries target multiple viral epitopes to maintain neutralizing potency against evolving SARS-CoV-2 variants.

Monoclonal antibodies bind human TIMP-2 with high affinity to enable sensitive detection in complex biological fluids.

Extracting Native Hapten from Brucella outer membrane eliminates false positives caused by cross-reactivity with enterobacteria and vaccination interference.

Silane-based self-assembled monolayers anchor tethered bilayer lipid membranes on transparent conducting oxides for stable biosensing.

Quantifying CD54 and IL-6 expression resolves inconsistent MSC potency from variable culture conditions.

Engineered monoclonal antibodies internalize upon binding guanylyl cyclase C, resolving the bottleneck of ineffective cellular delivery in cancer treatment.

VAPA biomarker kit detects extracellular vesicle markers in blood samples to identify hepatocellular carcinoma bone metastasis risk.

Heparin-coated solid supports isolate extracellular vesicles via affinity binding, resolving co-sedimentation of protein aggregates during ultracentrifugation.

A microfluidic device sorts and immobilizes nematodes to record electropharyngeograms.

Solution-phase synthesis creates nanostructured gold films that enhance near-infrared fluorescence and Raman scattering signals.

Fluorescent probes bind specific cellular markers to identify multipotent mesenchymal stem cell subpopulations within heterogeneous cultures.

Bead-immobilized plasma membranes enable direct G-protein activation monitoring, eliminating cross-talk and radioactive waste from indirect assays.

Colorimetric phytochemical analysis detects pesticide exposure in plants before visual symptoms appear, enabling early intervention and reducing chemical usage.

Counting marker-negative cells improves prognosis accuracy by detecting mesenchymal-type circulating tumor cells missed by standard epithelial marker methods.

Antibodies target the Ebola virus membrane proximal external region to bypass glycan shielding, enabling effective neutralization and diagnostic detection.